glutathione mutations in sclc patients RETRACTED ARTICLE: Novel prognostic biomarkers small cell lung cancer reveal mutational signatures, genomic mutations, and immune implications Increased antioxidative defense and reduced
Increased antioxidative defense and reduced advanced glycation end product formation by metabolic adaptation in non small cell lung cancer patients Nature Communications Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega Oncology Reports Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications
Pay in 4 interest-free payments of $6.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19



